Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 52-2451724 · Snapshot of IRS recognition, filing currency, financial health, and governance.
To advance knowledge on the structure, function and therapeutic application of Hyaluronan and its role in the structure and function of the extracellular matrix and cells and to support scientific research on the Hyaluronan molecule encompassing all 3 branches of medical Sciences.
Principal Officer
Stavros Garantziotis MD
Total Revenue
$23K
FY2024
Total Expenses
$55K
FY2024
Net Assets
$345K
Program Ratio
95.2%
expenses on programs
Employees
0
Volunteers
0
Board Members
0
Voting
0
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.